NCT07050004

Prevalence of Smoking After Lung Transplantation

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,099 (actual)
• Sponsor: Fondation Hôpital Saint-Joseph · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Smoking is one of the main risk factors for chronic obstructive pulmonary disease (COPD), the primary indication for lung transplantation (LT) in France. Resumption of smoking after transplantation is associated with an increased risk of graft dysfunction, neoplasia and reduced survival. The prevalence of resumption of smoking after transplantation is based on few data available in the literature and is estimated at between 0 and 15%. The aim of this study is to determine the prevalence of smoking in transplantation. These results will enable healthcare professionalś to carry out information, education, prevention and support actions to help patients stop smoking throughout the transplantation process.

Conditions

• Tobacco Smoking
• Lung Transplantation

Interventions

Type	Name	Description
BEHAVIORAL	SMOKING	Patients who agree to take part in the study will complete a questionnaire covering the pre- and post-transplant aspects of smoking on their lifestyle

Timeline

• Start date: 2023-05-01
• Primary completion: 2024-07-11
• Completion: 2024-12-11
• First posted: 2025-07-03
• Last updated: 2025-07-03

Locations

1 site across 1 country: France